Issue 11, 2011

Cleavable β-cyclodextrin nanocapsules incorporating GdIII-chelates as bioresponsive MRI probes

Abstract

Perthiolated β-cyclodextrin-based nanocapsules incorporating diaquo GdIII-complexes represent a promising new type of bioresponsive MRI contrast agent, showing a pronounced relaxivity change upon degradation in a reducing environment.

Graphical abstract: Cleavable β-cyclodextrin nanocapsules incorporating GdIII-chelates as bioresponsive MRI probes

Supplementary files

Article information

Article type
Communication
Submitted
07 Dec 2010
Accepted
11 Jan 2011
First published
26 Jan 2011

Chem. Commun., 2011,47, 3144-3146

Cleavable β-cyclodextrin nanocapsules incorporating GdIII-chelates as bioresponsive MRI probes

J. Martinelli, M. Fekete, L. Tei and M. Botta, Chem. Commun., 2011, 47, 3144 DOI: 10.1039/C0CC05428C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements